Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $1.345B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 5,617,599 | $181M | 13.5% | $25.89 | +14.5% | COM | 76155X100 |
| LAB | STANDARD BIOTOOLS INC | 61,907,605 | $168M | 12.5% | $2.41 | +0.4% | COM | 34385P108 |
| BLFS | BIOLIFE SOLUTIONS INC | 8,707,165 | $162M | 12.0% | $19.43 | -10.0% | COM NEW | 09062W204 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,069,000 | $138M | 10.3% | $100.84 | +21.5% | COM | 803607100 |
| RLAY | RELAY THERAPEUTICS INC | 7,423,574 | $61.62M | 4.6% | $23.10 | -57.8% | COM | 75943R102 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 358,000 | $53.5M | 4.0% | $138.08 | +20.8% | COM | 02043Q107 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,084,841 | $53.21M | 4.0% | $14.11 | +11.1% | COM | 05370A108 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,875,000 | $51.58M | 3.8% | $38.42 | -27.7% | COM | 45826J105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,116,867 | $47.87M | 3.6% | $33.80 | — | SPONSORED ADS | 86366E106 |
| EXAS | EXACT SCIENCES CORP | 650,000 | $44.89M | 3.3% | $74.77 | -15.4% | COM | 30063P105 |
| — | VERVE THERAPEUTICS INC | 3,059,094 | $40.62M | 3.0% | $45.54 | — | COM | 92539P101 |
| TNYA | TENAYA THERAPEUTICS INC | 6,732,971 | $35.21M | 2.6% | $12.86 | -62.8% | COM | 87990A106 |
| ILMN | ILLUMINA INC | 248,000 | $34.06M | 2.5% | $121.95 | +9.9% | COM | 452327109 |
| — | BLUEPRINT MEDICINES CORP | 326,378 | $30.96M | 2.3% | $3820.05 | — | COM | 09627Y109 |
| WGS | GENEDX HOLDINGS CORP | 3,136,411 | $28.64M | 2.1% | $7.89 | -23.9% | COM CL A | 81663L200 |
| NGNE | NEUROGENE INC | 524,616 | $26.7M | 2.0% | $14.32 | +133.2% | COM | 64135M105 |
| DNLI | DENALI THERAPEUTICS INC | 1,300,000 | $26.68M | 2.0% | $29.48 | -36.3% | COM | 24823R105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 800,000 | $25.49M | 1.9% | $17.09 | +49.3% | COM | 35104E100 |
| BEAM | BEAM THERAPEUTICS INC | 675,000 | $22.3M | 1.7% | $52.81 | -41.0% | COM | 07373V105 |
| VCYT | VERACYTE INC | 857,904 | $19.01M | 1.4% | $24.40 | 0.0% | COM | 92337F107 |
| PLRX | PLIANT THERAPEUTICS INC | 1,000,000 | $14.9M | 1.1% | $20.16 | -18.2% | COM | 729139105 |
| IPSC | CENTURY THERAPEUTICS INC | 3,206,380 | $13.4M | 1.0% | $25.37 | -83.3% | COM | 15673T100 |
| — | 2SEVENTY BIO INC | 2,000,000 | $10.7M | 0.8% | $9.15 | — | COMMON STOCK | 901384107 |
| ABCL | ABCELLERA BIOLOGICS INC | 2,360,129 | $10.69M | 0.8% | $10.18 | -49.9% | COM | 00288U106 |
| TNGX | TANGO THERAPEUTICS INC | 1,188,349 | $9.435M | 0.7% | $5.87 | +82.5% | COM | 87583X109 |
| CDXS | CODEXIS INC | 2,000,000 | $6.98M | 0.5% | $2.18 | +44.7% | COM | 192005106 |
| ABSI | ABSCI CORPORATION | 973,260 | $5.528M | 0.4% | $19.41 | -76.8% | COM | 00091E109 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $3.884M | 0.3% | $11.43 | -48.8% | COM | 69404D108 |
| KYTX | KYVERNA THERAPEUTICS INC | 150,000 | $3.726M | 0.3% | $27.84 | 0.0% | COM | 501976104 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 510,882 | $3.602M | 0.3% | $20.37 | -70.9% | COM | 61225M102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 150,000 | $3.57M | 0.3% | $15.37 | +45.1% | COM | 87164F105 |
| PRME | PRIME MEDICINE INC | 367,175 | $2.57M | 0.2% | $18.06 | -58.0% | COM | 74168J101 |
| — | GINKGO BIOWORKS HOLDINGS INC | 1,459,747 | $1.693M | 0.1% | $1.16 | — | CL A SHS | 37611X100 |
| NTLA | INTELLIA THERAPEUTICS INC | 50,000 | $1.375M | 0.1% | $38.42 | -27.7% | Call | 45826J105 |
| — | EXSCIENTIA PLC | 213,900 | $1.224M | 0.1% | $19.76 | — | ADS | 30223G102 |
| — | SINGULAR GENOMICS SYSTEMS IN | 1,323,885 | $681K | 0.1% | $18.57 | — | COM | 82933R100 |
| — | KRONOS BIO INC | 123,839 | $161K | 0.0% | $29.87 | — | COM | 50107A104 |